Obermatt

Yungjin Pharm

KSC:003520 · KR7003520004
PharmaceuticalsSmall

360° View

34
Price/Sales37
Price/Earnings25
Price/Book17
Dividend Yield1
Revenue Growth86
Profit Growth33
Capital Growth92
TSR 52w5
Leverage54
Liquidity68
Refinancing65
Combined52
Analyst Opinions
Pro Holdings22
Opinion Changes
Market Pulse1

Profile

CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeKOSE
Employees11
ISINKR7003520004
Last UpdateApr 2, 2026
Index & Theme
CardiovascularUrologyNutraceuticalPain ManagementInflammationNeurologyRespiratoryCentral Nervous SystemManufacturingMedicalPharmaceutical

Description

Analysis

Yungjin Pharm's 360° View rank of 34 places it below its peer average — better than 34% of its true peers.

It's growing solidly (63) and expensive versus peers (10). On safety it is very well financed (79), and the market shows skeptical sentiment (10). Taken together, its Combined rank of 52 reads as above its peer average.

360° rank · history

1007550250
34
2026

All-time high

64

Mar 2026

All-time low

34

Jun 2026

Average rank

49

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
37
Price/Earnings
25
Price/Book
17
Dividend Yield
1
Value (overall)
10

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Yungjin Pharm with its peers
Ildong Holdings
KSC:000230
83
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Whanin Pharm
KSC:016580
99
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Samil Pharmaceutical
KSC:000520
28
CountrySouth Korea
IndustryPharmaceuticals
SizeX-Small
Full Stock Analysis →
Dongwha Pharm
KSC:000020
44
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
CSPC Pharmaceutical
HKG:1093
79
CountryChina
IndustryPharmaceuticals
SizeX-Large
Full Stock Analysis →
Samsung Pharm
KSC:001360
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →